Stay updated on Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page
- Check7 days agoChange DetectedThe site revision identifier in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAccess to the NICARAGUA study record now shows a 403 Forbidden error, replacing the study details with an access-denied message.SummaryDifference19%

- Check56 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page, indicating a new release of the site template. This update reflects a platform-level change rather than modifications to the study data or content.SummaryDifference0.1%

- Check63 days agoChange DetectedA new line '2017 ( U.S. NIH Grant/Contract )' was added to the list of Other Study ID Numbers in the study record. This addition provides NIH funding metadata for the NICARAGUA trial.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a small platform update to the study page. This reflects an underlying system update rather than a modification to the study data.SummaryDifference0.1%

Stay in the know with updates to Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib & Cabozantinib in Advanced Urothelial Cancer Clinical Trial page.